ATE395600T1 - Verfahren zur diagnose von knochenmetastasen aus malignen tumoren - Google Patents

Verfahren zur diagnose von knochenmetastasen aus malignen tumoren

Info

Publication number
ATE395600T1
ATE395600T1 AT99938547T AT99938547T ATE395600T1 AT E395600 T1 ATE395600 T1 AT E395600T1 AT 99938547 T AT99938547 T AT 99938547T AT 99938547 T AT99938547 T AT 99938547T AT E395600 T1 ATE395600 T1 AT E395600T1
Authority
AT
Austria
Prior art keywords
bone metastasis
malignant tumors
diagnosing bone
marker
reflects
Prior art date
Application number
AT99938547T
Other languages
English (en)
Inventor
Etsuro Ogata
Mitsuru Koizumi
Shunji Takahashi
Original Assignee
Etsuro Ogata
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Etsuro Ogata filed Critical Etsuro Ogata
Application granted granted Critical
Publication of ATE395600T1 publication Critical patent/ATE395600T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
AT99938547T 1998-08-21 1999-08-20 Verfahren zur diagnose von knochenmetastasen aus malignen tumoren ATE395600T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23614698 1998-08-21

Publications (1)

Publication Number Publication Date
ATE395600T1 true ATE395600T1 (de) 2008-05-15

Family

ID=16996446

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99938547T ATE395600T1 (de) 1998-08-21 1999-08-20 Verfahren zur diagnose von knochenmetastasen aus malignen tumoren

Country Status (7)

Country Link
US (1) US7632486B1 (de)
EP (1) EP1107006B1 (de)
JP (1) JP4420565B2 (de)
AT (1) ATE395600T1 (de)
AU (1) AU5302599A (de)
DE (1) DE69938729D1 (de)
WO (1) WO2000011480A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005064307A2 (en) 2003-12-23 2005-07-14 Roche Diagnostics Gmbh Method of assessing rheumatoid arthritis by measuring anti-ccp and interleukin 6
WO2009083020A1 (en) * 2007-12-28 2009-07-09 F. Hoffmann-La Roche Ag Assessment of physiological conditions
WO2012122334A2 (en) * 2011-03-08 2012-09-13 The Johns Hopkins University Procollagen carboxy-terminal propeptides as a target and treatment for angiogenesis related diseases
CA2834778C (en) 2011-05-02 2019-08-13 Exelixis, Inc. Method of treating cancer and bone cancer pain
CA2987372C (en) 2015-06-04 2024-02-20 Nihon Medi-Physics Co., Ltd. Diagnostic imaging agent for early bone metastasis from cancer
CN112384806A (zh) * 2018-08-03 2021-02-19 西托根有限公司 癌症的骨转移诊断用组成物及包括其的试剂盒
WO2020027484A1 (ko) * 2018-08-03 2020-02-06 서울대학교병원 암의 골전이 진단용 조성물 및 이를 포함하는 키트
CN117561445A (zh) * 2021-03-24 2024-02-13 积水医疗株式会社 Ⅰ型胶原c末端肽的免疫学分析方法

Also Published As

Publication number Publication date
JP4420565B2 (ja) 2010-02-24
EP1107006A1 (de) 2001-06-13
AU5302599A (en) 2000-03-14
EP1107006B1 (de) 2008-05-14
WO2000011480A1 (fr) 2000-03-02
DE69938729D1 (de) 2008-06-26
EP1107006A4 (de) 2002-03-06
US7632486B1 (en) 2009-12-15

Similar Documents

Publication Publication Date Title
DE69738077D1 (de) Tiermodelle für die menschliche prostatakrebsfortschreitung
ATE399560T1 (de) Pharmazeutische zusammensetzungen enthaltend arsentrioxid zur behandlung von nicht-hodgkihn- lymphome
ATE294595T1 (de) Radioaktive zusammensetzungen zur behandlung von prostatatumoren
DE69918089D1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
ATE345387T1 (de) Verbindungen und verfahren für therapie und diagnose von lungenkrebs
ATE469242T1 (de) Zusammensetzungen und methoden zur identifizierung und zum targeting von krebszellen aus dem verdauungskanal
DE60329274D1 (de) Kontrastmittel und verfahren zum imaging von naaldase oder psma
EP1099102A4 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
EP0967015A3 (de) Verwendung von Ferrocenylliganden zur katalytischen enantioselektiven Hydrierung
DE60016548D1 (de) Snail, neuer marker für die entwicklung von tumoren und zielprotein neuer antitumoraler verbindungen
ATE395600T1 (de) Verfahren zur diagnose von knochenmetastasen aus malignen tumoren
ATE350662T1 (de) Markerproteine für prostatakrebs
AU3392901A (en) Proteins
DE60122673D1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
DE60113968D1 (de) Diagnose von brustkrebs unter verwendung von bcmp-7 als marker
WO2003037257A3 (en) Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750
DE60030270D1 (de) Fettsaure analoge zur diagnose von kranzarterie erkrankungen
DE60139150D1 (de) Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs
ATE329597T1 (de) Die verwendung von einer 4- pyridylmethylphtalazine enthaltenden kombination zur behandlung von tumoren
DE69931644D1 (de) Verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gynäkologischer krebserkrankungen
DE69940474D1 (de) Verfahren zur diagnose von prostatakrebs
ATE520031T1 (de) Ibc-1 (invasive breast cancer-1), ein bei brustkrebs amplifiziertes mutmassliches onkogen
ATE240352T1 (de) Komplexverbindungen zur diagnose von gefässerkrankungen
DE60041561D1 (de) Zusammensetzungen und Methoden zur Diagnose von Tumoren
WO2003028537A3 (en) Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties